26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives To examine how much of the observed rapid decrease in mortality from coronary heart disease in Poland after the political, social, and economic transformation in the early 1990s could be explained by the use of medical and surgical treatments and how much by changes in cardiovascular risk factors.

          Design A modelling study.

          Setting Sources of data included controlled trials and meta-analyses, national surveys, and official statistics.

          Participants Population of adults aged 25-74 in Poland in 1991-2005.

          Main outcome measures Number of deaths prevented or postponed in 2005 attributable to specific treatments for coronary heart disease and changes in risk factors. A previously validated epidemiological model for coronary heart disease was used to combine and analyse data on the uptake and effectiveness of specific cardiac treatments and changes in risk factors. The observed fall in deaths from coronary heart disease from 1991 to 2005 was then partitioned among specific treatments and risk factor changes.

          Results From 1991 to 2005, the death rate from coronary heart disease in Poland halved, resulting in 26 200 fewer coronary deaths in 2005 in people aged 25-74. About 37% (minimum estimate 13%, maximum estimate 77%) of this decrease was attributable to treatments, including treatments for heart failure (12%), initial treatments for acute coronary syndrome (9%), secondary prevention treatments after myocardial infarction or revascularisation (7%), chronic angina treatments (3%), and other treatments (6%). About 54% of the fall was attributed to changes in risk factors (minimum estimate 41%, maximum estimate 65%), mainly reductions in total cholesterol concentration (39%) and an increase in leisuretime physical activity (10%); however, these were partially offset by increases in body mass index (−4%) and prevalence of diabetes (−2%). Blood pressure fell in women, explaining about 29% of their decrease in mortality, but rose in men generating a negative influence (−8%). About 15% of the observed decrease in mortality was attributable to reduced smoking in men but was negligible in women.

          Conclusions Over half of the recent fall in mortality from coronary heart disease in Poland can be attributed to reductions in major risk factors and about one third to evidence based medical treatments.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: not found
          • Article: not found

          CIRCULATION

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997.

            In Finland since the 1980s, coronary heart disease mortality has declined more than might be predicted by risk factor reductions alone. The aim of this study was to assess how much of the decline could be attributed to improved treatments and risk factor reductions. The authors used the cell-based IMPACT mortality model to synthesize effectiveness of treatments and risk factor reductions with data on treatments administered to patients and trends in cardiovascular risk factors in the population. Cardiovascular risk factors were measured in random samples of patients in 1982 (n=8,501) and 1997 (n=4,500). Mortality and treatment data were obtained from the National Causes of Death Register, Hospital Discharge Register, social insurance data, and medical records. Estimated and observed changes in coronary heart disease mortality were used as main outcome measures. Between 1982 and 1997, coronary heart disease mortality rates declined by 63%, with 373 fewer deaths in 1997 than expected from baseline mortality rates in 1982. Improved treatments explained approximately 23% of the mortality reduction, and risk factors explained some 53-72% of the reduction. These findings highlight the value of a comprehensive strategy that promotes primary prevention programs and actively supports secondary prevention. It also emphasizes the importance of maximizing population coverage of effective treatments.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002.

              Coronary heart disease (CHD) mortality rates have been falling in Sweden since the 1980s. We used the previously validated IMPACT CHD model to examine how much of the mortality decrease in Sweden between 1986 and 2002 could be attributed to medical and surgical treatments, and how much to changes in cardiovascular risk factors. The IMPACT mortality model was used to combine and analyse data on uptake and effectiveness of cardiological treatments and risk factor trends in Sweden. The main data sources were official statistics, national quality of care registers, published trials and meta-analyses, and national population surveys. Between 1986 and 2002, CHD mortality rates in Sweden decreased by 53.4% in men and 52.0% in women aged 25-84 years. This resulted in 13 180 fewer deaths in 2002. Approximately 36% of this decrease was attributed to treatments in individuals and 55% to population risk factor reductions. Adverse trends were seen for diabetes and overweight. More than half of the substantial CHD mortality decrease in Sweden between 1986 and 2002 was attributable to reductions in major risk factors, mainly a large decrease in total serum cholesterol. These findings emphasize the value of a comprehensive strategy that promotes primary prevention and evidence-based medical treatments, especially secondary prevention.
                Bookmark

                Author and article information

                Contributors
                Role: research and teaching assistant
                Role: lecturer in clinical epidemiology
                Role: professor
                Role: research and teaching assistant
                Role: research and teaching assistant
                Role: professor
                Role: senior lecturer
                Role: associate professor
                Role: professor of clinical epidemiology
                Journal
                BMJ
                bmj
                BMJ : British Medical Journal
                BMJ Publishing Group Ltd.
                0959-8138
                1468-5833
                2012
                2012
                25 January 2012
                : 344
                : d8136
                Affiliations
                [1 ]Department of Hypertension and Diabetology, Medical University in Gdansk, ul. Dębinki 7, 80-211 Gdansk, Poland
                [2 ]Division of Public Health, University of Liverpool, Liverpool L69 3GB, UK
                [3 ]Department of Epidemiology, CVD Prevention and Health Promotion, Institute of Cardiology, ul. Niemodlińska 33, 04-635, Warsaw, Poland
                [4 ]Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James’s Hospital, Dublin 8, Republic of Ireland
                Author notes
                Correspondence to: T Zdrojewski tz@ 123456gumed.edu.pl
                Article
                banp876722
                10.1136/bmj.d8136
                3266431
                22279114
                f5839f02-9ea5-48ad-a74c-b10902189118
                © Bandosz et al 2012

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

                History
                : 31 August 2011
                Categories
                Research
                Smoking and Tobacco
                Clinical Trials (Epidemiology)
                Epidemiologic Studies
                Drugs: Cardiovascular System
                Hypertension
                Ischaemic Heart Disease
                Health Education
                Health Promotion
                Smoking

                Medicine
                Medicine

                Comments

                Comment on this article